CoverageForm 410-K10-Q8-K13D13G13F

COP · Conocophillips - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · COP

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$15.76B-$15.03B$14.00B$16.52B-$13.04B$13.62B$13.85B-
Cost of Revenue$6.28B-$5.86B$5.08B$6.19B-$4.75B$4.86B$5.33B-
Gross Profit$9.48B-$9.17B$8.92B$10.33B-$8.29B$8.76B$8.51B-
R&D----------
SG&A$193.00M-$271.00M$250.00M$191.00M-$186.00M$164.00M$178.00M-
Total Operating Expenses$2.28B-$2.63B$2.57B$2.51B-$2.26B$2.16B$2.02B-
D&A$2.91B-$2.92B$2.84B$2.75B-$2.39B$2.33B$2.21B-
Operating Income$3.36B-$2.93B$3.66B$3.81B-$4.10B$3.36B$4.56B-
Interest Expense----------
Income Tax$1.18B-$1.20B$1.05B$1.62B-$1.18B$1.33B$1.26B-
Net Income$2.18B-$1.73B$1.97B$2.85B-$2.06B$2.33B$2.55B-
EPS - Basic$1.78-$1.38$1.56$2.23-$1.77$1.99$2.16-
EPS - Diluted$1.78-$1.38$1.56$2.23-$1.76$1.98$2.15-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$5.88B$6.50B$5.26B$4.90B$6.31B$5.61B$5.22B$4.29B$5.57B$5.63B
Accounts Receivable----------
Inventory$1.91B$1.87B$1.72B$1.90B$1.84B$1.81B$1.50B$1.45B$1.44B$1.40B
Accounts Payable$7.02B$6.22B$6.25B$6.52B$7.35B-----
Current Assets$16.23B$15.53B$15.88B$13.94B$16.91B$15.65B$13.98B$13.73B$13.72B$14.33B
Total Assets$122.72B$121.94B$122.47B$122.60B$124.25B$122.78B$96.70B$95.99B$95.35B$95.92B
Current Liabilities$12.59B$11.97B$12.01B$10.99B$13.33B$12.12B$10.77B$10.32B$10.16B$10.01B
Long-term Debt----------
Total Liabilities$58.18B$57.45B$57.55B$57.03B$59.02B$57.98B$46.82B$46.25B$46.02B$46.65B
Stockholders' Equity$64.54B$64.49B$64.92B$65.57B$65.24B$64.80B$49.88B$49.74B$49.33B$49.28B
Retained Earnings$70.02B$68.86B$68.46B$67.71B$66.72B$64.87B$63.46B$62.31B$60.90B$59.27B

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow$4.29B---$6.12B---$4.99B-
Investing Cash Flow($2.81B)---($2.35B)---($2.14B)-
Financing Cash Flow($2.19B)---($3.14B)---($2.83B)-
CapEx----------
Free Cash Flow----------

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin60.1%-61.0%63.7%62.5%-63.6%64.3%61.5%-
Operating margin21.3%-19.5%26.1%23.1%-31.4%24.7%32.9%-
EBITDA margin39.8%-38.9%46.4%39.7%-49.8%41.8%48.9%-
Net margin13.9%-11.5%14.1%17.2%-15.8%17.1%18.4%-
Free cash flow margin----------
FCF / Net income----------
R&D / Revenue----------
SG&A / Revenue1.2%-1.8%1.8%1.2%-1.4%1.2%1.3%-
Effective tax rate35.1%-41.1%34.7%36.2%-36.4%36.3%33.0%-
Return on assets1.8%-1.4%1.6%2.3%-2.1%2.4%2.7%-
Return on equity3.4%-2.7%3.0%4.4%-4.1%4.7%5.2%-
Return on invested capital----------
Liquidity
Current ratio1.291.301.321.271.271.291.301.331.351.43
Quick ratio1.141.141.181.101.131.141.161.191.211.29
Cash ratio0.470.540.440.450.470.460.480.420.550.56
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage----------
Equity multiplier1.901.891.891.871.901.891.941.931.931.95
Liabilities / Assets0.470.470.470.470.470.470.480.480.480.49
Efficiency
Asset turnover0.13-0.120.110.13-0.130.140.15-
Inventory turnover3.29-3.402.683.36-3.173.363.70-
Days sales outstanding----------
Days inventory outstanding111d-107d136d109d-115d109d99d-
Days payable outstanding408d-389d468d433d-----
Cash conversion cycle----------
Valuation
P / E74.2x-68.5x57.5x47.1x-59.8x57.8x59.2x-
P / B2.5x-1.8x1.7x2.1x-2.5x2.7x3.0x-
P / S10.3x-7.8x8.1x8.1x-9.4x9.8x10.8x-
EV / EBITDA24.9x-19.3x16.6x19.5x-18.1x22.7x21.4x-
Growth
Revenue growth (YoY)-4.6%-15.3%2.8%19.3%--8.5%10.3%-6.5%-
Revenue CAGR (3y)2.1%--10.6%-12.9%-2.4%-3.9%10.1%9.5%-
Revenue CAGR (5y)8.3%-27.9%28.4%21.8%-5.3%10.2%6.6%-
Gross profit growth (YoY)-8.2%-10.6%1.8%21.3%--4.7%13.3%-1.8%-
Operating income growth (YoY)-11.7%--28.6%8.8%-16.5%-----
Net income growth (YoY)-23.4%--16.2%-15.4%11.7%--26.4%4.3%-12.6%-
EPS growth (YoY)-20.2%--21.6%-21.2%3.7%--24.1%7.6%-9.7%-
EPS CAGR (3y)-9.2%--27.0%-26.7%-20.2%--0.4%8.5%42.1%-
EPS CAGR (5y)18.9%--45.4%---8.5%7.2%6.1%-
FCF growth (YoY)----------
FCF CAGR (5y)----------
Book value growth (YoY)-1.1%-0.5%30.2%31.8%32.3%31.5%4.5%4.7%3.2%2.7%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$121.86B total
Total Segments$60.90B · 50.0%
Lower Forty Eight Segment$41.40B · 34.0%
Europe Middle East And North Africa Segment$6.49B · 5.3%
Alaska Segment$5.64B · 4.6%
Canada Operating Segment$5.60B · 4.6%
Asia Pacific Operating Segment$1.77B · 1.5%
Corporate Segment$63.00M · 0.1%

Geographic

$58.94B total
US$46.61B · 79.1%
Non Us$12.33B · 20.9%

Peer comparison

Same SIC group: Petroleum Refining

CompanyRevenue (last FY)Net marginROE
CVX$189.03B6.5%6.6%
PBF$29.33B-0.5%-3.0%
MPC$132.70B3.0%23.4%
PSX$132.38B3.3%15.1%
DK$10.72B-0.2%-4.2%

Comparing CONOCOPHILLIPS against the 5 most active filers in the same SIC group.

Dividends

$3.30/share trailing 12 months · +5.8% YoY

Ex-datePer share
May 11, 2026$0.8400
Feb 18, 2026$0.8400
Nov 17, 2025$0.8400
Aug 18, 2025$0.7800
May 19, 2025$0.7800
Feb 14, 2025$0.7800
Nov 8, 2024$0.7800
Aug 12, 2024$0.7800
May 10, 2024$0.7800
Feb 15, 2024$0.7800
Nov 13, 2023$0.5800
Sep 27, 2023$0.6000
Aug 15, 2023$0.5100
Jun 26, 2023$0.6000
May 15, 2023$0.5100
Mar 28, 2023$0.6000
Feb 13, 2023$0.5100
Dec 23, 2022$0.7000
Nov 14, 2022$0.5100
Sep 28, 2022$1.4000
Aug 15, 2022$0.4600
Jun 27, 2022$0.7000
May 16, 2022$0.4600
Mar 30, 2022$0.3000